Abpro

Abpro Holdings, Inc. is a clinical-stage biotechnology company headquartered in the Boston area (Woburn / Burlington, Massachusetts) that develops next-generation multispecific antibody therapeutics for oncology and ophthalmology. Its DiversImmune antibody-discovery platform and MultiMab multispecific-engineering platform are used to build bispecific and tetravalent T-cell-engager constructs, led by ABP-102/CT-P72, a tetravalent bispecific HER2 x CD3 T-cell engager partnered with Celltrion, alongside the ABP-110, ABP-150 and ABP-201 programs. Abpro is a drug developer rather than a software company: its public web surface is a corporate and investor-relations site, and it publishes no developer program, public API, SDK, webhook surface, or machine-readable specification of any kind.

Abpro is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Antibody Therapeutics, and Oncology.

Abpro’s developer surface includes product news and 10 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyPharmaceuticalsAntibody TherapeuticsOncologyLife SciencesDrug DiscoveryClinical Stage

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 7.9/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Commercial Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/abpro: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

News

Careers

InvestorRelations

InvestorRelations

Other 3

Properties that don't map to a standard resource type

Technology

Technology

Pipeline

Pipeline

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: abpro
name: Abpro
description: 'Abpro Holdings, Inc. is a clinical-stage biotechnology company headquartered in the Boston area (Woburn / Burlington,
  Massachusetts) that develops next-generation multispecific antibody therapeutics for oncology and ophthalmology. Its DiversImmune
  antibody-discovery platform and MultiMab multispecific-engineering platform are used to build bispecific and tetravalent
  T-cell-engager constructs, led by ABP-102/CT-P72, a tetravalent bispecific HER2 x CD3 T-cell engager partnered with Celltrion,
  alongside the ABP-110, ABP-150 and ABP-201 programs. Abpro is a drug developer rather than a software company: its public
  web surface is a corporate and investor-relations site, and it publishes no developer program, public API, SDK, webhook
  surface, or machine-readable specification of any kind.'
image: https://abpro.co/wp-content/uploads/2023/05/Abpro_logo_with_trademark-transparent.png
url: https://raw.githubusercontent.com/api-evangelist/abpro/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Antibody Therapeutics
- Oncology
- Life Sciences
- Drug Discovery
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abpro-domain-security.yml
- type: Website
  url: https://abpro.co/
- type: About
  url: https://abpro.co/about-us/
- type: Technology
  url: https://abpro.co/technology/
- type: Pipeline
  url: https://abpro.co/pipeline/
- type: News
  url: https://abpro.co/news/
- type: Careers
  url: https://abpro.co/careers/
- type: Contact
  url: https://abpro.co/contact/
- type: InvestorRelations
  url: https://investor.abpro.co/
- type: PrivacyPolicy
  url: https://abpro.co/privacy-policy/
- type: SecondaryMarket
  url: https://forgeglobal.com/abpro_stock/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Abpro is a clinical-stage antibody-therapeutics developer whose product is a drug pipeline rather than software,
    and its entire published surface is the 33-page corporate WordPress site listed in sitemap_index.xml — every developer
    path (/developers, /docs, /api, /graphql, /openapi.json) 404s and there is no github.com/abpro organization.
  evidence:
  - url: https://abpro.co/openapi.json
    status: 404
  - url: https://abpro.co/graphql
    status: 404
  - url: https://abpro.co/developers
    status: 404
  - url: https://abpro.co/.well-known/agent-card.json
    status: 404
  - url: https://abpro.co/.well-known/agent.json
    status: 404
  - url: https://abpro.co/llms.txt
    status: 404
  - url: https://api.github.com/orgs/abpro
    status: 404
  - url: https://investor.abpro.co/
    status: 403
  - url: https://abpro.co/sitemap_index.xml
    status: 200
  checked: '2026-08-06'